Loading...

APC anti-mouse NK-1.1 Antibody

Pricing & Availability
Clone
PK136 (See other available formats)
Regulatory Status
RUO
Other Names
NKR-P1C, NKR-P1B, Ly-55, CD161, CD161b, CD161c
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
PK136_APC_1_110210
C57BL/6 mouse splenocytes were stained with CD49b (DX5) FITC and NK1.1 (clone PK136) APC (top) or mouse IgG2a APC isotype control (bottom).
  • PK136_APC_1_110210
    C57BL/6 mouse splenocytes were stained with CD49b (DX5) FITC and NK1.1 (clone PK136) APC (top) or mouse IgG2a APC isotype control (bottom).
  • PK136_APC_2_110210
See APC spectral data
Cat # Size Price Quantity Check Availability Save
108709 25 µg 88 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108710 100 µg 292 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The NK-1.1 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 108712).

Application References

(PubMed link indicates BioLegend citation)
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  2. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  3. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  4. Hernández–Santos N, et al. 2018. Cell Host Microbe. 1.313194444. PubMed
  5. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  6. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  7. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  8. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  9. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  10. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  11. Shen T, et al. 2019. Cell Death Discov. 5:123. PubMed
  12. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  13. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  14. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  15. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  16. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  17. Liu CF, et al. 2017. Front Immunol. 1.445833333. PubMed
  18. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  19. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  20. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  21. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  22. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  23. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  24. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  25. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  26. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  27. Zenker S, et al. 2014. J Immunol. 192:2830. PubMed
  28. Huang W, et al. 2014. J Leukoc Biol. 96:55. PubMed
  29. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  30. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  31. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  32. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  33. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  34. Terhorst D, et al. 2015. J Immunol. 195: 4953 - 4961. PubMed
  35. Hirata Y, et al. 2015. PLoS One. 10: 0141785. PubMed
  36. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  37. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  38. Solaymani-Mohammadi S, et al. 2016. J Leukoc Biol. 99: 475 - 482. PubMed
  39. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  40. Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
  41. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  42. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  43. Janakiram N, et al. 2016. Sci Rep. 6:37046. PubMed
  44. Zhang H, et al. 2017. Immunol Cell Biol. 10.1038/icb.2017.11. PubMed
  45. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  46. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  47. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  48. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  49. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  50. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  51. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  52. Hutter K, et al. 2020. FEBS J. . PubMed
  53. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  54. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  55. Wei SC, et al. 2020. Cancer Discov. . PubMed
  56. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  57. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  58. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  59. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  60. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  61. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  62. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  63. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  64. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  65. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  66. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  67. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  68. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  69. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  70. Guo L, et al. 2021. Front Immunol. 12:785457. PubMed
  71. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  72. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  73. Hester AK, et al. 2022. Cell Rep. 38:110363. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  76. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  77. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  78. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  79. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  80. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  81. Kim S, et al. 2021. Elife. 10:. PubMed
  82. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  83. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  84. Sun SJ, et al. 2022. Commun Biol. 5:867. PubMed
  85. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  86. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  87. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  88. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  89. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
  90. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  91. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  92. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  93. Gawish R, et al. 2022. Elife. 11:. PubMed
  94. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  95. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  96. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  97. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  98. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  99. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  100. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  101. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  102. Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed
  103. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  104. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  105. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  106. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  107. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  108. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  109. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  110. Leick MB, et al. 2022. Cancer Cell. 40:494. PubMed
  111. Wight AE, et al. 2022. Proc Natl Acad Sci U S A. 119:e2200757119. PubMed
  112. Pi C, et al. 2022. Cancers (Basel). 14:. PubMed
  113. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  114. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  115. Roussel-Queval A, et al. 2023. STAR Protoc. 4:102119. PubMed
  116. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  117. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  118. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
RRID
AB_313396 (BioLegend Cat. No. 108709)
AB_313397 (BioLegend Cat. No. 108710)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12.08.2016

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account